Johnson & Johnson
(UKEX:JNJ)
â‚´
5947
0 (0%)
Market Cap: 14.82 Til
Enterprise Value: 15.47 Til
PE Ratio: 24.01
PB Ratio: 4.98
GF Score: 84/100 Johnson & Johnson at Citi Healthcare Conference (Virtual) Transcript
Feb 23, 2022 / 04:00PM GMT
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Well, everybody, thank you for joining us for the next session of the Citi Healthcare Conference. This one, I'm very pleased to have with us, Ashley McEvoy from Johnson & Johnson. Ashley, thank you for joining us this morning.
Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of Med Tech
Joanne, it's a pleasure to see you. Although I'm not there live with you, but I'm looking forward to that time. Thanks for having me.
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Me too. Enough of the virtual stuff.
Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of Med Tech
Yes.
Questions & Answers
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Anyway, I do have to ask about what you're seeing in the current backdrop of procedures, because as earnings cycle has moved on, we're
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot